Genius Sports Limited (GENI) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$4.76
Price Target
$12.10
Target Range
$5.00 — $17.00
Analyst Rating
Buy
Forward P/E52.4x
Trailing P/E-10.8x
Forward PEG—
Implied Growth+121.1%
Median Target$12.00
Analyst Spread99.2%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$5
+4.9%
Consensus
$12
+153.9%
Bull Case
$17
+256.8%
GENI Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Genius Sports Limited (GENI) has a Wall Street consensus price target of $12.10, based on estimates from 19 covering analysts. With the stock currently trading at $4.76, this represents a potential upside of +153.9%. The company has a market capitalization of $1.17B.
Analyst price targets range from a low of $5.00 to a high of $17.00, representing a 99% spread in expectations. The median target of $12.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 17 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, GENI trades at a trailing P/E of -10.8x and forward P/E of 52.4x. Analysts expect EPS to grow +121.1% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Communication Services stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+70.6%
Avg Forward P/E33.7x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SRADSportradar Group AG | $4.0B | $13.64 | $21.75 | +59.5% | Buy | 33.1x | 20 |
 DKNGDraftKings Inc. | $12.5B | $25.22 | $36.88 | +46.2% | Buy | 99.1x | 48 |
 PENNPENN Entertainment, Inc. | $2.2B | $16.77 | $19.88 | +18.5% | Buy | 23.0x | 47 |
 FLUTFlutter Entertainment plc | $17.6B | $101.16 | $227.86 | +125.2% | Buy | 16.5x | 24 |
 MGMMGM Resorts International | $9.8B | $38.11 | $39.71 | +4.2% | Buy | 22.1x | 36 |
 RCELAVITA Medical, Inc. | $128M | $4.17 | $6.75 | +61.7% | Buy | — | 7 |
 NFLXNetflix, Inc. | $374.0B | $88.26 | $116.29 | +31.8% | Buy | 24.8x | 99 |
 GOOGLAlphabet Inc. | $4.8T | $397.99 | $406.28 | +2.1% | Buy | 29.6x | 82 |
 TTDThe Trade Desk, Inc. | $11.2B | $23.49 | $37.12 | +58.0% | Buy | 21.2x | 46 |
 FUBOfuboTV Inc. | $317M | $10.77 | $43.00 | +299.3% | Hold | — | 14 |
Upside Potential Comparison
FUBOFLUTRCELSRADTTDDKNGNFLXPENNSee GENI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GENI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GENI vs NFLX
Side-by-side business, growth, and profitability comparison vs Netflix, Inc..
Start ComparisonGENI — Frequently Asked Questions
Quick answers to the most common questions about buying GENI stock.
What is the GENI stock price target for 2026?
The consensus Wall Street price target for GENI is $12.1, representing 153.9% upside from the current price of $4.765. With 19 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is GENI a buy, sell, or hold?
GENI has a consensus rating of "Buy" based on 19 Wall Street analysts. The rating breakdown is predominantly bullish, with 17 Buy/Strong Buy ratings. The consensus 12-month price target of $12.1 implies 153.9% upside from current levels.
Is GENI stock overvalued or undervalued?
At a forward P/E of 52.4202x, GENI trades at a premium valuation. The consensus price target of $12.1 (153.9% upside) suggests analysts still see growth justifying the multiple.
How high can GENI stock go?
The most bullish Wall Street analyst has a price target of $17 for GENI, while the most conservative target is $5. The consensus of $12.1 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover GENI stock?
GENI is well covered by analysts, with 19 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 17 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the GENI stock forecast?
The 12-month GENI stock forecast based on 19 Wall Street analysts shows a consensus price target of $12.1, with estimates ranging from $5 (bear case) to $17 (bull case). The median consensus rating is "Buy".
What is GENI's forward P/E ratio?
GENI trades at a forward P/E ratio of 52.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy GENI stock?
Wall Street analysts are very optimistic on GENI, with a "Buy" consensus rating and $12.1 price target (153.9% upside). 17 of 19 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do GENI price targets vary so much?
GENI analyst price targets range from $5 to $17, a 99% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12.1 consensus represents the middle ground.